Skip to main content
. 2005 Aug;54(8):1169–1173. doi: 10.1136/gut.2004.055251

Table 1.

 Characteristic of the study population

Ondansetron (n = 18) Placebo (n = 18)
Sex 10F/8M 15F/3M
Age (y) 48.2 (8.3) 52.5 (11.4)
Body weight (kg) 63.5 (10.5) 62.8 (10.2)
Height (cm) 160 (20.6) 162 (7.3)
ALT (U/l) 72.8 (58.0) 64.5 (50.9)
Hep C viral load (106 copies/ml) 11.1 (10.6) 7.0 (7.5)
METAVIR score
    Activity index 1.2 (0.4) 1.2 (0.9)
    Fibrosis index 1.2 (0.5) 1.1 (0.4)

Hep C, hepatitis C virus; ALT, alanine aminotransferase.

There were no significant differences between the groups.